Sign In
to Vote &
Create Storyboards.
 
Many people suffer from chronic inflammation because their immune systems overreact to 'self' tissue. Scientists believe that a small molecule known as Interleukin 21 is a promising therapeutic target in such cases.
1
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard